NanoViricides Inc. (NNVC)

[Its_lose_not_loose]

The company is hustling to choose its final CoV SARS 2 candidate. By May 20 we narrowed down the candidates to 5 by testing against similar 'cousin' viruses, so next step is testing against the actual pandemic CoV S2 itself and choosing the one final candidate. We've been in discussions with two BSL3/4 labs since early May so we should be hearing soon about those tests starting. There is enormous time pressure on developing CV therapies and vaccines so the news from NNVC should be steady and ongoing if things are progressing. If we don't hear about our candidate(s) going into BSL 3/4 lab testing against CoV S2 in the next week or two, it'll raise questions about our credibility. Things are moving fast for other drug candidates, they should move fast for us. If they aren't, fears of platform viability will come back.

After hearing about the CoV S2 testing arrangements, we should then start hearing more about our pre IND talks with the FDA. And then results from the tests. And the results will likely be positive, given the positive testing against the similar, cousin CVs. Coronas are RNA viruses and notoriously tough to treat (one of the reasons why there are no cold cures), so this is exciting.

We will also be hearing soon that TheraCour and NNVC reached a licensing deal. That will not really be news, but it will be good to see.